208 related articles for article (PubMed ID: 25773208)
1. Treatment of pulmonary disease caused by non-tuberculous mycobacteria.
van Ingen J
Lancet Respir Med; 2015 Mar; 3(3):179-80. PubMed ID: 25773208
[No Abstract] [Full Text] [Related]
2. Antibiotic treatment for nontuberculous mycobacterial lung disease.
Kang YA; Koh WJ
Expert Rev Respir Med; 2016; 10(5):557-68. PubMed ID: 26967761
[TBL] [Abstract][Full Text] [Related]
3. Introducing the new BTS Guideline: Management of non-tuberculous mycobacterial pulmonary disease (NTM-PD).
Haworth CS; Floto RA
Thorax; 2017 Nov; 72(11):969-970. PubMed ID: 29054887
[TBL] [Abstract][Full Text] [Related]
4. Management of nontuberculous mycobacterial (NTM) lung disease.
Philley JV; Griffith DE
Semin Respir Crit Care Med; 2013 Feb; 34(1):135-42. PubMed ID: 23460013
[TBL] [Abstract][Full Text] [Related]
5. ECCMID 2018 meeting report: the continuing clinical challenge of nontuberculous mycobacteria lung disease.
Mason I
Future Microbiol; 2018 Sep; 13():1347-1349. PubMed ID: 30256153
[No Abstract] [Full Text] [Related]
6. Advances in the management of pulmonary disease due to Mycobacterium abscessus complex.
Koh WJ; Stout JE; Yew WW
Int J Tuberc Lung Dis; 2014 Oct; 18(10):1141-8. PubMed ID: 25216826
[TBL] [Abstract][Full Text] [Related]
7. Unresolved issues in treatment outcome definitions for nontuberculous mycobacterial pulmonary disease.
Moon SM; Jhun BW; Daley CL; Koh WJ
Eur Respir J; 2019 May; 53(5):. PubMed ID: 30819812
[No Abstract] [Full Text] [Related]
8. A shorter treatment duration may be sufficient for patients with Mycobacterium massiliense lung disease than with Mycobacterium abscessus lung disease.
Lyu J; Kim BJ; Kim BJ; Song JW; Choi CM; Oh YM; Lee SD; Kim WS; Kim DS; Shim TS
Respir Med; 2014 Nov; 108(11):1706-12. PubMed ID: 25245792
[TBL] [Abstract][Full Text] [Related]
9. Mycobacterium triplex pulmonary disease with acquired macrolide resistance in immunocompetent patients.
Matsuda S; Suzuki S; Morimoto K; Aono A; Nishio K; Asakura T; Sasaki Y; Namkoong H; Nishimura T; Ogata H; Hasegawa N; Kurashima A; Ishii M; Tatsumi K; Mitarai S; Goto H
Clin Microbiol Infect; 2018 Jun; 24(6):671-672. PubMed ID: 29309938
[No Abstract] [Full Text] [Related]
10. [Not Available].
Pedersen AA; Dahl VN; Hilberg O; Løkke A; Fløe A
Ugeskr Laeger; 2024 Apr; 186(14):. PubMed ID: 38606709
[TBL] [Abstract][Full Text] [Related]
11. Mycobacterium shimoidei-cavitary pulmonary disease with favorable outcome.
Popovic V; Arar D; Popovic DR; Barisic I; Tonkic M; Peric I; Novak A; Rubic Z; Katalinic-Jankovic V; Makek MJ; Goic-Barisic I
Folia Microbiol (Praha); 2018 Mar; 63(2):249-252. PubMed ID: 28913757
[TBL] [Abstract][Full Text] [Related]
12. [Pulmonary infections with non-tuberculous mycobacteria].
Fløe A; Hermansen TS; Lillebæk T; Hilberg O
Ugeskr Laeger; 2016 Jun; 178(25):. PubMed ID: 27401987
[TBL] [Abstract][Full Text] [Related]
13. Treatment Approaches to Mycobacterium abscessus Pulmonary Disease.
Holt MR; Baird T
Clin Chest Med; 2023 Dec; 44(4):785-798. PubMed ID: 37890916
[TBL] [Abstract][Full Text] [Related]
14. Cefoxitin continuous infusion for lung infection caused by the Mycobacterium abscessus group.
Czaja CA; Levin A; Moridani M; Krank JL; Curran-Everett D; Anderson PL
Antimicrob Agents Chemother; 2014 Jun; 58(6):3570-1. PubMed ID: 24733469
[No Abstract] [Full Text] [Related]
15.
Braganza Menezes DA; Dedicoat MJ; Robertson A
BMJ Case Rep; 2018 Feb; 2018():. PubMed ID: 29420243
[TBL] [Abstract][Full Text] [Related]
16. Infections caused by opportunist mycobacteria: a review.
Grange JM; Yates MD
J R Soc Med; 1986 Apr; 79(4):226-9. PubMed ID: 3517327
[No Abstract] [Full Text] [Related]
17. Pulmonary Mycobacterium abscessus Infection in a Patient with Triple A Syndrome.
Emiralioğlu N; Ersöz DD; Oğuz B; Saribas Z; Yalçın E; Özçelik U; Özsürekçi Y; Cengiz AB; Kiper N
J Trop Pediatr; 2016 Aug; 62(4):324-7. PubMed ID: 27080471
[TBL] [Abstract][Full Text] [Related]
18. [Progress in the treatment of Mycobacterium abscessus pulmonary disease].
Cui XC; Li Q; Zhou M
Zhonghua Jie He He Hu Xi Za Zhi; 2021 Mar; 44(3):257-260. PubMed ID: 33721940
[TBL] [Abstract][Full Text] [Related]
19. Mycobacterium shimoidei, a Rare Pulmonary Pathogen, Queensland, Australia.
Baird TM; Carter R; Eather G; Thomson R
Emerg Infect Dis; 2017 Nov; 23(11):1919-1922. PubMed ID: 29048290
[TBL] [Abstract][Full Text] [Related]
20. Drug treatment of pulmonary nontuberculous mycobacterial disease in HIV-negative patients: the evidence.
van Ingen J; Ferro BE; Hoefsloot W; Boeree MJ; van Soolingen D
Expert Rev Anti Infect Ther; 2013 Oct; 11(10):1065-77. PubMed ID: 24124798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
